Vir Biotechnology to Participate in Upcoming Investor Healthcare Conferences
24 February 2024 - 12:05AM
Business Wire
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that
management will be participating in the following upcoming investor
conferences during the month of March:
- TD Cowen 44th Annual Health Care Conference at the Boston
Marriott Copley Place in Boston. Marianne De Backer, M.Sc., Ph.D.,
MBA, Chief Executive Officer, is scheduled to participate in a
fireside chat on Monday, March 4, at 2:50 p.m. ET / 11:50 a.m.
PT.
- Leerink Partners Global Biopharma Conference at the
Fontainebleau Hotel in Miami Beach. Vir management will be hosting
one-on-one investor meetings on Monday, March 11 and Tuesday, March
12.
- Barclays 26th Annual Global Healthcare Conference at Loews
Miami Beach Hotel in Miami. Marianne De Backer, M.Sc., Ph.D., MBA,
Chief Executive Officer, is scheduled to participate in a fireside
chat on Tuesday, March 12, at 7:30 a.m. ET / 4:30 a.m. PT.
Live webcasts of the fireside chats can be accessed under Events
& Presentations in the Investors section of the Vir website at
www.vir.bio and will be archived there for 30 days.
About Vir Biotechnology, Inc.
Vir Biotechnology, Inc. is an immunology company focused on
powering the immune system to transform lives by treating and
preventing infectious diseases and other serious conditions,
including viral-associated diseases. Vir has assembled two
technology platforms that are designed to modulate the immune
system by exploiting critical observations of natural immune
processes. Its current clinical development pipeline consists of
product candidates targeting hepatitis delta and hepatitis B
viruses and human immunodeficiency virus. Vir has several
preclinical candidates in its pipeline, including those targeting
influenza A and B, COVID-19, RSV/MPV and HPV. Vir routinely posts
information that may be important to investors on its website.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240220184688/en/
Carly Scaduto Senior Director, Media Relations cscaduto@vir.bio
+1-314-368-5189
Investors Richard Lepke Senior Director, Investor
Relations rlepke@vir.bio +1 978-973-9986
Vir Biotechnology (NASDAQ:VIR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Vir Biotechnology (NASDAQ:VIR)
Historical Stock Chart
From Apr 2023 to Apr 2024